Psyence Biomedical Ltd. Common Shares (PBM) — Net Asset Quality Index
Psyence Biomedical Ltd. Common Shares (PBM) has a Net Asset Quality Index of 92.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $12.81 Million minus total liabilities of $943.07K yields net assets of $11.87 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Psyence Biomedical Ltd. Common Shares debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Psyence Biomedical Ltd. Common Shares Net Asset Quality Index Over Time (2021–2025)
This chart shows how Psyence Biomedical Ltd. Common Shares's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of September 2025, the index stands at 92.6%, representing net assets of $11.87 Million against total assets of $12.81 Million USD. For live market cap and overall valuation, see Psyence Biomedical Ltd. Common Shares stock valuation.
Annual Net Asset Quality Index for Psyence Biomedical Ltd. Common Shares (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Psyence Biomedical Ltd. Common Shares from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Psyence Biomedical Ltd. Common Shares (PBM) strategic asset index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 91.9% | $6.72 Million | $7.32 Million | $594.37K | ▲ +1061.0 pp |
| 2024 | -969.2% | $-10.97 Million | $1.13 Million | $12.10 Million | ▼ -1063.7 pp |
| 2023 | 94.5% | $244.66 Million | $258.93 Million | $14.27 Million | ▲ +0.9 pp |
| 2022 | 93.6% | $239.84 Million | $256.22 Million | $16.38 Million | ▼ -4.3 pp |
| 2021 | 97.9% | $4.80 Million | $4.90 Million | $101.08K | — |